Fundraising FoxBiotech Startups
11,114 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
Ocean Biomedical is a biopharmaceutical company developing drugs for oncology, fibrosis, and infectious diseases by licensing technologies from academic research institutions including Brown University and Rhode Island Hospital. The company's pipeline includes monoclonal antibodies and small molecule candidates for non-small cell lung cancer, glioblastoma, idiopathic pulmonary fibrosis, and malaria, with preclinical programs anticipated to advance to clinical development.
0 investors
0 investors
0 investors
OcuDyne develops an investigational ophthalmic device called OPTiC that is currently undergoing clinical trials in the United States. The company operates in the medical device and healthcare sector, focused on eye care applications.
0 investors
Ocugen develops gene therapies, including a modifier gene therapy platform aimed at treating inherited retinal diseases and blindness. The company focuses on addressing unmet medical needs in vision-related and eye diseases.
0 investors
0 investors
Okogen is a clinical-stage ophthalmic pharmaceutical company developing a treatment for acute infectious conjunctivitis, covering both bacterial and viral forms. Its lead product is in clinical trials as a single treatment for all forms of the condition.
0 investors
0 investors
Oleander Medical Technologies develops Targeted Osmotic Lysis, a medical technology approach for treating cancer in animals. The company works with veterinary hospitals and regulatory consultants to advance its therapeutic platform.
0 investors
0 investors
0 investors
OncBioMune is a clinical-stage biopharmaceutical company developing novel cancer immunotherapy products using proprietary vaccine technology designed to stimulate immune response against cancer cells. The company focuses on treatments for prostate cancer and other oncology indications, with its lead product in Phase 2 development.
0 investors
Oncobiomix develops AI-powered microbiome diagnostics and therapeutics, using gut microbiome analysis as a "biosensor" for cancer detection and gut health. The company offers microbiome testing (RebiomiX) in which samples undergo microbial DNA extraction and AI-based analysis to generate health reports.
0 investors
Insight Molecular Diagnostics (iMDx) develops molecular diagnostic tests for transplantation and oncology, including blood-based donor-derived cell-free DNA assays for transplant monitoring and gene-expression tests for cancer immunotherapy guidance. Its products serve researchers, clinicians, hospitals, and healthcare systems across clinical practice and translational research.
0 investors
0 investors
0 investors
0 investors
Onconetix is a commercial-stage biotechnology company that researches, develops, and commercializes proprietary therapeutics, diagnostics, and services in oncology. It serves clinicians and patients, with a product line that includes the Proclarix diagnostic.
0 investors
Traws Pharma (formerly Onconova Therapeutics) develops investigational antiviral agents targeting respiratory viral infections and certain cancers, with four clinical-stage programs including a cap-dependent endonuclease inhibitor for influenza and bird flu, a protease inhibitor for COVID-19, and two kinase inhibitors for solid tumors and blood cancers.
0 investors
0 investors
0 investors
0 investors